These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35997232)

  • 1. Evaluation of Francisella orientalis ΔpdpA as a Live Attenuated Vaccine against Piscine Francisellosis in Nile Tilapia.
    de Alexandre Sebastião F; Hansen JD; Soto E
    J Aquat Anim Health; 2022 Sep; 34(3):134-139. PubMed ID: 35997232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an inactivated whole cell vaccine through immersion for immunoprophylaxis of Francisella orientalis infections in Nile tilapia (Oreochromis niloticus L.) fingerlings and juveniles.
    Oliveira TF; Quieróz GA; Leibowitz MP; Gomes Leal CA
    Fish Shellfish Immunol; 2022 Aug; 127():405-411. PubMed ID: 35772679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated Francisella asiatica iglC mutant induces protective immunity to francisellosis in tilapia.
    Soto E; Wiles J; Elzer P; Macaluso K; Hawke JP
    Vaccine; 2011 Jan; 29(3):593-8. PubMed ID: 20600508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of IglC and GroEL recombinant vaccines for francisellosis in Nile tilapia, Oreochromis niloticus.
    Shahin K; Pirezan F; Rogge M; LaFrentz BR; Shrestha RP; Hildebrand M; Lu F; HogenEsch H; Soto E
    Fish Shellfish Immunol; 2020 Oct; 105():341-349. PubMed ID: 32712230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a bivalent mucoadhesive nanovaccine to prevent francisellosis and columnaris diseases in Nile tilapia (Oreochromis niloticus).
    Bunnoy A; Thompson KD; Thangsunan P; Chokmangmeepisarn P; Yata T; Pirarat N; Kitiyodom S; Thangsunan P; Sukkarun P; Prukbenjakul P; Panthukumphol N; Morishita M; Srisapoome P; Rodkhum C
    Fish Shellfish Immunol; 2023 Jul; 138():108813. PubMed ID: 37182796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of an inactivated whole-cell injection vaccine for nile tilapia, Oreochromis niloticus (L), against multiple isolates of Francisella noatunensis subsp. orientalis from diverse geographical regions.
    Shahin K; Shinn AP; Metselaar M; Ramirez-Paredes JG; Monaghan SJ; Thompson KD; Hoare R; Adams A
    Fish Shellfish Immunol; 2019 Jun; 89():217-227. PubMed ID: 30951851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of temperature and salt concentration on Francisella noatunensis subsp. orientalis infections in Nile tilapia Oreochromis niloticus.
    Soto E; Abrams SB; Revan F
    Dis Aquat Organ; 2012 Nov; 101(3):217-23. PubMed ID: 23324418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of piscine francisellosis in Largemouth Bass from a public display exhibit in north-central Florida, USA.
    Sheehy A; Shahin K; Camus A; Francis-Floyd R; Yanong R; Fogelson S; Soto E
    J Aquat Anim Health; 2023 Dec; 35(4):201-210. PubMed ID: 37965692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Francisella noatunensis subsp. orientalis pathogenesis analyzed by experimental immersion challenge in Nile tilapia, Oreochromis niloticus (L.).
    Soto E; Kidd S; Mendez S; Marancik D; Revan F; Hiltchie D; Camus A
    Vet Microbiol; 2013 May; 164(1-2):77-84. PubMed ID: 23415477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of enrofloxacin in treatment of Francisella orientalis infections in juvenile Nile tilapia (Oreochromis niloticus L.).
    de Oliveira TF; de Queiróz GA; Pimenta Leibowitz M; Leal CAG
    J Vet Pharmacol Ther; 2023 Sep; 46(5):344-352. PubMed ID: 37051920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the pathogenicity of Francisella orientalis in Nile tilapia (Oreochromis niloticus), Asian seabass (Lates calcarifer) and largemouth bass (Micropterus salmoides) through experimental intraperitoneal infection.
    Poudyal S; Pulpipat T; Wang PC; Chen SC
    J Fish Dis; 2020 Sep; 43(9):1097-1106. PubMed ID: 32700447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vaccination of Nile tilapia (Oreochromis niloticus) against francisellosis elevates specific antibody titres in serum and mucus.
    Hoare R; Leigh W; Limakom T; Wongwaradechkul R; Metselaar M; Shinn AP; Ngo TPH; Thompson KD; Adams A
    Fish Shellfish Immunol; 2021 Jun; 113():86-88. PubMed ID: 33826937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole cell inactivated autogenous vaccine effectively protects red Nile tilapia (Oreochromis niloticus) against francisellosis via intraperitoneal injection.
    Ramírez-Paredes JG; Mendoza-Roldan MA; Lopez-Jimena B; Shahin K; Metselaar M; Thompson KD; Penman DJ; Richards RH; Adams A
    J Fish Dis; 2019 Aug; 42(8):1191-1200. PubMed ID: 31184398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Francisella noatunensis subsp. orientalis with Oreochromis mossambicus bulbus arteriosus cell line.
    Soto E; Yun S; Lewis J; Kearney MT; Hansen J
    Microb Pathog; 2017 Apr; 105():326-333. PubMed ID: 28286149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of piscine francisellosis differs amongst tilapia species (Oreochromis spp.) in a controlled challenge with Francisella noatunensis subsp. orientalis.
    Klinger-Bowen R; Tamaru C; McGovern-Hopkins K; Li Y; Sithole F; Kearney MT; Francis S; Soto E
    J Fish Dis; 2016 Nov; 39(11):1305-1312. PubMed ID: 26916547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of size and temperature at vaccination on immunization and protection conferred by a live attenuated Francisella noatunensis immersion vaccine in red hybrid tilapia.
    Soto E; Brown N; Gardenfors ZO; Yount S; Revan F; Francis S; Kearney MT; Camus A
    Fish Shellfish Immunol; 2014 Dec; 41(2):593-9. PubMed ID: 25462454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Francisella noatunensis subsp. orientalis isolated from Nile tilapia Oreochromis niloticus farmed in Lake Yojoa, Honduras.
    Soto E; Shahin K; Talhami JJ; Griffin MJ; Adams A; Ramírez-Paredes JG
    Dis Aquat Organ; 2019 Feb; 133(2):141-145. PubMed ID: 31019138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel development of cationic surfactant-based mucoadhesive nanovaccine for direct immersion vaccination against Francisella noatunensis subsp. orientalis in red tilapia (Oreochromis sp.).
    Thangsunan P; Kitiyodom S; Srisapoome P; Pirarat N; Yata T; Thangsunan P; Boonrungsiman S; Bunnoy A; Rodkhum C
    Fish Shellfish Immunol; 2022 Aug; 127():1051-1060. PubMed ID: 35872335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular detection of Francisella noatunensis subsp. orientalis in cultured Nile tilapia (Oreochromis niloticus L.) in three Brazilian states.
    Sebastião FA; Pilarski F; Kearney MT; Soto E
    J Fish Dis; 2017 Nov; 40(11):1731-1735. PubMed ID: 28449216
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of florfenicol for control of mortality associated with Francisella noatunensis subsp. orientalis in Nile tilapia, Oreochromis niloticus (L.).
    Soto E; Kidd S; Gaunt PS; Endris R
    J Fish Dis; 2013 Apr; 36(4):411-8. PubMed ID: 23134104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.